|
Reznik E.V., Golubev Yu.Yu., Zhuravlev A.K., Yurtaeva N.V., Ischenko G.Yu.
Arterial hypertension and longevity
|
№10 / 2022
|
|
Martynov M.Yu., Gudkova V.V., Koltsova E.A., Razinskaya O.D., Abramenkova N.N., Solntsev E.S., Ulyanov D.I., Chuprina S.E.
Arterial hypertension and posterior reversible encephalopathy syndrome
|
№9 / 2022
|
|
Sementsova N.A., Chesnikova A.I., Safronenko V.A., Skarzhinskaya N.S.
Estimation of central aortic pressure in patients with arterial hypertension and atherosclerosis of the arteries of the lower extremities
|
№8 / 2022
|
|
Larina V.N., Fedorova E.V., Sayno O.V., Mironova T.N., Orlov D.A.
The incidence of abdominal obesity and its association with risk factors for cardiovascular disease in middle-aged people
|
№8 / 2022
|
|
Ovchinnikov Yu.V., Mostovoy L.V., Zaitsev A.A.
New criteria for long-term CPAP therapy adherence in obstructive sleep apnea syndrome and arterial hypertension patients
|
№5 / 2022
|
|
Rezova N.V., Pertsev A.V., Shkatova Ya.S.
The special role of melatonin in the development of hypertension
|
№4 (приложение) / 2022
|
|
Polyakova O.A., Ostroumova O.D. , Arablinsky A.V.
Drug safety and polymorbidity as important components of rational pharmacotherapy in cardiology
|
№4 / 2022
|
|
Derevyanchenko M.V., Fedotov V.V., Shaposhnikova M.Yu., Kolodin S.V.
Assessment of the risk of developing cardiovascular diseases on the SCORE-2 and SCORE 2-OP scale in patients with arterial hypertension using software tools
|
№3 / 2022
|
|
Larina V.N.
Treatment of arterial hypertension in high risk comorbid patients: possibilities of amlodipine and losartan combination
|
№1 / 2022
|
|
Korneeva E.V., Voevoda M.I., Semaev S.E., Maksimov V.N.
Clinical significance of gene polymorphisms in the development of metabolic syndrome in the young population
|
№9 / 2021
|
|
Heylo T.S., Danilogorskaya Yu.A., Nazarenko G.B., Gladysheva E.G.
Dynamics of microcirculation indices in patients with chronic ischemic diseases of the central nervous and cardiovascular systems
|
№8 / 2021
|
|
Eliseeva l.N., Kartashova S.V.
Mexidol® and mexidol® forte 250 in consecutive therapy of cognitive disorders in comorbid patients with joint pathology on the background of arterial hypertension and ischemic heart disease
|
№6 / 2020
|
Русский
